PodcastIntel
Sign in Get Started Free
Urology Times
Urology Times

Prof Declan Murphy discusses PROTEUS pathologic response findings in prostate cancer

Aug 31, 2026 · 0:03:42
Listen to Episode
✨ AI Summary
  • Prof. Murphy discusses PROTEUS trial pathologic response findings.
  • Apalutamide plus ADT shows specific pathologic responses in prostate cancer.
  • Findings may shape future prostate cancer treatment strategies.

Guests on This Episode

DM
Declan Murphy
researcher · 1 podcast appearance
›

More from Urology Times

Urology Times
When surgery may be needed for prolonged ischemic priapism
Oct 12, 2026 · 0:02:34
Urology Times
Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence
Oct 12, 2026 · 0:03:53
Urology Times
How can urologists separate personalized medicine from marketing?
Oct 9, 2026 · 0:04:29
Urology Times
Why ctDNA serves as a rule-out in NeoBLAST's response assessment
Oct 8, 2026 · 0:06:56
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Urology Times and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →